EVERSANA (Canada)
In research, EVERSANA (Canada) stands highest in Medicine (#8,688 of 10,443 worldwide) and Health Sciences (#10,051 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Economics and Econometrics and Economics, Econometrics and Finance — Economics and Econometrics is 11.4× its share of world research.
- World rank, 2022–2025
- #20,669 of 28,054 · #36,473 all time
- Rank in Canada
- #322 of 403
- Research works
- 161 fractional, all time
- Citations
- 859 5.3 per fractional work
- Top-10% rate
- 10.8% record average 16.5%
- Open access
- 59% world 28%
What is EVERSANA (Canada) known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #8,688 of 10,443 | 15.8% | 62 | — | |
| Health SciencesDomain | #10,051 of 11,982 | 15.6% | 64 | — |
Each strip is that field’s whole ranked pool, with the notch where EVERSANA (Canada) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does EVERSANA (Canada) specialise in?
Where its research is concentrated relative to its size: Economics and Econometrics takes 11.4× the share of its output that it takes of world research.
- Economics and EconometricsSubfield · 21.2 works11×
- Economics, Econometrics and FinanceField · 21.3 works8.4×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 8.4×. Every wedge is a field page.
- Economics, Econometrics and Finance 8.4×
- Immunology and Microbiology 3.9×
- Decision Sciences 3.6×
- Medicine 2.7×
- Pharmacology, Toxicology and Pharmaceutics 2.2×
- Mathematics 1.2×
- Biochemistry, Genetics and Molecular Biology 0.9×
- Health Professions 0.7×
- Computer Science 0.5×
- Veterinary 0.5×
- Psychology 0.3×
- Engineering 0.3×
- Energy 0.2×
- Business, Management and Accounting 0.2×
- Nursing 0.2×
- Dentistry 0.1×
- Social Sciences 0.1×
- Environmental Science 0.1×
- Physics and Astronomy 0.1×
- Neuroscience 0.1×
- Materials Science 0.0×
- Chemistry 0.0×
Who are the top researchers at EVERSANA (Canada)?
Ranked on the composite score, Chris Cameron, Joanne Ellis and Nicole Ferko lead among researchers whose main affiliation is EVERSANA (Canada).
- 1 Chris Cameron Canada · #38,661 worldwide 987 citations · 31 works
- 2 Joanne Ellis Canada · #1,141,122 worldwide 0 citations · 24 works
- 3 Nicole Ferko Canada · #1,540,158 worldwide 8 citations · 19 works
Which keywords describe research at EVERSANA (Canada)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Quality of Life, Cost-effectiveness Analysis, Health Utility Measures, Epidemiology, Pharmaceutical Industry, Drug Development Costs, Generic Drugs and Prognostic Factors.
- Insulin Therapy
- Intraocular Lens Implantation
- Quality Assessment
- Genomic Aberrations
- Chronic Lymphocytic Leukemia
- Lymphoma
- Bioanalytical Methods
- Diabetes
- Primary Care
- Glycemic Control
- Clinical Guidelines
- Genomic Profiling
- Precision Medicine
- Clinical Outcomes
- Rituximab
- Immunotherapy
- Pharmaceutical Industry
- Drug Development Costs
- Epidemiology
- Cost-effectiveness Analysis
- Quality of Life
- Health Utility Measures
- Clinical Trials
- Generic Drugs
- Prognostic Factors
- Chemotherapy
- Biomarkers
- Autoantibodies
- Genetic Mutations
- Biopharmaceuticals
- Glaucoma
- Monoclonal Antibodies
- Clinical Practice Guidelines
- Immunogenicity
- Biosimilars
- Prostate Cancer
- Forecasting
- Minimal Residual Disease
- Femtosecond Laser
- TGF-ß
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Quality of Life17▲ 9.9×12 topics
- Cost-effectiveness Analysis14▲ 141×1 topic
- Health Utility Measures14▲ 141×1 topic
- Epidemiology8▲ 1.82×35 topics
- Clinical Trials4▲ 5.3×10 topics
- Drug Development Costs4▲ 128×1 topic
- Generic Drugs4▲ 128×1 topic
- Pharmaceutical Industry4▲ 90×2 topics
- Prognostic Factors4▲ 7.4×8 topics
- Immunotherapy4▲ 4.5×10 topics
- Chemotherapy3▲ 3.8×12 topics
- Rituximab3▲ 18×3 topics
- Biomarkers3▲ 3.5×8 topics
- Clinical Outcomes3▲ 11×4 topics
- Autoantibodies3▲ 9.5×6 topics
- Precision Medicine3▲ 4.7×4 topics
- Genetic Mutations2▲ 4.9×6 topics
- Genomic Profiling2▲ 20×2 topics
- Biopharmaceuticals2▲ 40×3 topics
- Clinical Guidelines2▲ 7.1×6 topics
- Glaucoma2▲ 14×3 topics
- Glycemic Control2▲ 14×4 topics
- Monoclonal Antibodies2▲ 23×3 topics
- Primary Care2▲ 5.4×4 topics
- Clinical Practice Guidelines2▲ 3.6×6 topics
- Diabetes2▲ 4.0×4 topics
- Immunogenicity2▲ 44×3 topics
- Bioanalytical Methods2▲ 91×1 topic
- Biosimilars2▲ 91×1 topic
- Lymphoma2▲ 11×2 topics
- Prostate Cancer2▲ 14×3 topics
- Chronic Lymphocytic Leukemia2▲ 39×1 topic
- Forecasting2▲ 9.0×2 topics
- Genomic Aberrations2▲ 39×1 topic
- Minimal Residual Disease2▲ 24×2 topics
- Quality Assessment2▲ 9.0×2 topics
- Femtosecond Laser2▲ 32×1 topic
- Intraocular Lens Implantation2▲ 59×1 topic
- TGF-ß2▲ 9.9×3 topics
- Insulin Therapy2▲ 12×3 topics
Which research topics does EVERSANA (Canada) publish most on?
By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy, Biosimilars and Bioanalytical Methods and Chronic Lymphocytic Leukemia Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 14 works
- 2 Pharmaceutical Economics and Policy Economics and Econometrics 4 works
- 3 Biosimilars and Bioanalytical Methods Immunology 2 works
- 4 Chronic Lymphocytic Leukemia Research Genetics 2 works
- 5 Intraocular Surgery and Lenses Ophthalmology 2 works
- 6 Multiple Myeloma Research and Treatments Hematology 2 works
- 7 Innovation Policy and R&D Economics and Econometrics 1 works
- 8 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 1 works
- 9 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 1 works
- 10 Clinical practice guidelines implementation Public Health, Environmental and Occupational Health 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has EVERSANA (Canada)'s research output changed?
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Burlington
- Boehringer Ingelheim (Canada)
- Cytodiagnostics (Canada)
- Nalco (Canada)
- Semtech (Canada)
- Joseph Brant Hospital
- Forming Technologies (Canada)
- Outotec (Canada)
- ON Semiconductor (Canada)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.